Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acelrx Pharmaceutica (NQ: ACRX )

1.200 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 28, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.200
Bid (Size) 1.200 (1)
Ask (Size) 1.350 (78)
Prev. Close 1.200
Today's Range 1.200 - 1.200
52wk Range 1.020 - 2.940
Shares Outstanding 119,102,999
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AcelRx, Rocket, 360 DigiTech, and Piedmont Lithium and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX
Pomerantz LLP announces that a class action lawsuit has been filed against AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX) and certain of its officers. The class action, filed... 
From PR Newswire

Performance

YTD
-4.00%
-4.00%
1 Month
-20.00%
-20.00%
3 Month
-10.45%
-10.45%
6 Month
-47.37%
-47.37%
1 Year
-1.64%
-1.64%

More News

Read More
DEADLINE ALERT for SPCE, FREQ, ACRX, and RLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
From GlobeNewswire News Releases
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ACRX
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – ACRX
From GlobeNewswire News Releases
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)
From PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AcelRx, Ocugen, Tarena, and DraftKings and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) Investors
From PR Newswire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors With Losses Over $100K to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRX
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]